Etoricoxib – 15 years in Russia: the main results in the treatment of rheumatic diseases
Background. According to epidemiological studies, chronic musculoskeletal pain affects more than 30% of people worldwide, causing a huge personal and social burden. Nonsteroidal anti-inflammatory drugs are widely used to treat musculoskeletal pain. The drug etoricoxib, highly selective for COX-2, is...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Russo |
| Gepubliceerd in: |
Open Systems Publication
2024-01-01
|
| Reeks: | Лечащий Врач |
| Onderwerpen: | |
| Online toegang: | https://journal.lvrach.ru/jour/article/view/1179 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|